Please use this identifier to cite or link to this item:
http://repo.knmu.edu.ua/handle/123456789/18542
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kuzhko, Mykhailo | - |
dc.contributor.author | Gumeniuk, Mykola | - |
dc.contributor.author | Butov, Dmytro | - |
dc.contributor.author | Tlustova, Tetiana | - |
dc.contributor.author | Denysov, Oleksii | - |
dc.contributor.author | Sprynsian, Tetiana | - |
dc.date.accessioned | 2017-12-06T10:12:22Z | - |
dc.date.available | 2017-12-06T10:12:22Z | - |
dc.date.issued | 2017-09-09 | - |
dc.identifier.citation | Features of intravenous anti TB therapy in patients with first diagnosed pulmonary TB in the intensive phase of treatment / M. Kuzhko, M. Gumeniuk, D. Butov, T. Tlustova, O. Denysov, T. Sprynsian // European Respiratory Society : International congress 2017, Milan, Italy, 9–13 September 2017. – Milan, 2017. – P. 4551. | ru_RU |
dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/18542 | - |
dc.description.abstract | Background. We determined the effectiveness of intravenous anti-TB drugs compared with their oral administration during the intensive phase of treatment. Methods. 152 patients with newly diagnosed destructive pulmonary TB were randomized into 2 groups: Main (n=65) who received isoniazid (0.3 g), ethambutol (1.2 g) and sodium rifamycin (0.6 g) iv with pyrazinamide (2.0 g) per os and control (n=87) who received standard chemotherapy with the same drugs in the same doses orally. Results. After intensive phase sputum conversion was found in all the patients main group and 71 (81.6±4.1 %) patients control p<0.05. Time of sputum conversion in main group was 1.6±0.1 months and 1.9±0.1 months in control, p>0.05. In patients with destructive TB time to sputum conversion was 1.7±0.1 months in main group and 2.2±0.2 months in control, p<0.05. Time of cavities healing in main group was 2.9±0.2 months and 3.9±0.2 months in the control, p<0.05. Conclusions. Use of iv isoniazid, ethambutol and sodium rifamycin in the intensive phase of chemotherapy resulted in a significant reduction in terms of sputum conversion. | ru_RU |
dc.language.iso | en | ru_RU |
dc.subject | intravenous anti TB therapy | ru_RU |
dc.subject | pulmonary TB | ru_RU |
dc.title | Features of intravenous anti TB therapy in patients with first diagnosed pulmonary TB in the intensive phase of treatment | ru_RU |
dc.type | Thesis | ru_RU |
Appears in Collections: | Наукові роботи молодих вчених. Кафедра фтизіатрії та пульмонології |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.